XML 34 R23.htm IDEA: XBRL DOCUMENT
v3.25.3

FAIR VALUE MEASUREMENT (Tables) | 9 Months Ended
--- | ---
Sep. 28, 2025
Fair Value Disclosures [Abstract] |
Fair Value Measurements, Recurring and Nonrecurring | Our assets measured at fair value on a recurring basis consisted of the following:
| September 28, 2025
(in thousands) | Total fair value | Quoted prices in active markets for identical assets (level 1) | Significant other observable inputs (level 2) | Significant unobservable inputs (level 3)
Cash and cash equivalents | $ | 19,893 |  | $ | 19,893 |  | $ | — |  | $ | — |
Restricted cash and cash equivalents | 30,896 |  | 30,896 |  | — |  | — |
Cash, cash equivalents and restricted cash and cash equivalents (1) | $ | 50,789 |  | $ | 50,789 |  | $ | — |  | $ | — |
Municipal debt securities | $ | 7,891 |  | $ | — |  | $ | 7,891 |  | $ | — |
Corporate debt securities | 55,645 |  | — |  | 55,645 |  | — |
Agency mortgage-backed securities | 5,124 |  | — |  | 5,124 |  | — |
U.S. government and agency securities | 4,960 |  | — |  | 4,960 |  | — |
Restricted investments classified as held-to-maturity (2) | $ | 73,620 |  | $ | — |  | $ | 73,620 |  | $ | — |
| December 29, 2024
(in thousands) | Total fair value | Quoted prices in active markets for identical assets (level 1) | Significant other observable inputs (level 2) | Significant unobservable inputs (level 3)
Cash and cash equivalents | $ | 22,536 |  | $ | 22,536 |  | $ | — |  | $ | — |
Restricted cash and cash equivalents | 38,564 |  | 38,564 |  | — |  | — |
Cash, cash equivalents and restricted cash and cash equivalents (1) | $ | 61,100 |  | $ | 61,100 |  | $ | — |  | $ | — |
Municipal debt securities | $ | 22,355 |  | $ | — |  | $ | 22,355 |  | $ | — |
Corporate debt securities | 63,512 |  | — |  | 63,512 |  | — |
Agency mortgage-backed securities | 11,754 |  | — |  | 11,754 |  | — |
U.S. government and agency securities | 971 |  | — |  | 971 |  | — |
Restricted investments classified as held-to-maturity (2) | $ | 98,592 |  | $ | — |  | $ | 98,592 |  | $ | — |
(1)Cash, cash equivalents and restricted cash and cash equivalents include money market funds, deposits and investments with original maturities of three months or less. (2)Refer to Note 4: Restricted Cash, Cash Equivalents and Investments for additional details on our held-to-maturity debt securities. Assets measured at fair value on a nonrecurring basis In addition to assets that are recorded at fair value on a recurring basis, impairment tests may subject our reporting units with goodwill and other intangible assets to nonrecurring fair value measurement. We performed our annual impairment test for goodwill and indefinite-lived intangible assets as of the first day of fiscal second quarter of 2025. Refer to Note 6: Goodwill and Intangible Assets for additional details on the impairment charges, valuation methodologies, and inputs used in the fair value measurements. For our annual goodwill impairment test as of the first day of fiscal second quarter of 2025, the fair value of each reporting unit was estimated using an equal weighting of the income and market approaches. The various inputs to these fair value models are considered Level 3. As a result of the test, all of our reporting units with remaining goodwill had a fair value in excess of their respective carrying value. For our annual indefinite-lived intangible asset impairment test as of the first day of fiscal second quarter of 2025, the fair value of our trademarks were estimated using the relief from royalty method. The various inputs to this fair value model are considered Level 3. As a result of the test, our SMX trademark with a carrying value of $2.7 million was written down to its fair value, and an impairment charge of $0.2 million was recognized on our Consolidated Statements of Operations and Comprehensive Income (Loss) for the thirty-nine weeks ended September 28, 2025.

X
- Definition Tabular disclosure of financial instrument measured at fair value on recurring or nonrecurring basis. Includes, but is not limited to, instrument classified in shareholders' equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 100 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration